About
Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to commercial manufacturing for small molecules and biologics. It also manufactures and sells specialized fermentation-based active pharmaceutical ingredients, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company was incorporated in 2006 and is based in Bengaluru, India.
Key Metrics
as of Sep 2026Market Cap52,607 Cr
P/E88.70
Div Yield0.21 %
Book Value₹54.20
52w High₹974.00
52w Low₹579.00
Face Value₹2.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | 384.00 | 582.00 | 417.00 | 552.00 | 538.00 | 479.00 | 498.00 | 525.00 |
| Expenses | 253.00 | 316.00 | 254.00 | 327.00 | 343.00 | 281.00 | 331.00 | 324.00 |
| Operating Profit | 131.00 | 267.00 | 163.00 | 226.00 | 195.00 | 198.00 | 167.00 | 201.00 |
| OPM % | 34.00 | 46.00 | 39.00 | 41.00 | 36.00 | 41.00 | 33.00 | 38.00 |
| Other Income | 29.00 | 62.00 | 15.00 | 54.00 | 28.00 | 38.00 | 24.00 | 28.00 |
| Depreciation | 22.00 | 26.00 | 27.00 | 24.00 | 23.00 | 21.00 | 20.00 | 19.00 |
| Interest | 1.00 | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 |
| Profit before tax | 136.00 | 301.00 | 150.00 | 253.00 | 199.00 | 213.00 | 170.00 | 207.00 |
| Tax % | 25.00 | 30.00 | 25.00 | 22.00 | 25.00 | 42.00 | 25.00 | 18.00 |
| Net Profit | 102.00 | 212.00 | 112.00 | 198.00 | 148.00 | 123.00 | 128.00 | 170.00 |
| EPS in Rs | 1.81 | 3.77 | 2.00 | 3.53 | 2.64 | 2.19 | 2.29 | 3.05 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,089.00 | 1,841.00 | 1,418.00 | 1,057.00 | 1,231.00 | 1,103.00 | 633.00 | 626.00 |
| Expenses | 1,238.00 | 1,151.00 | 912.00 | 626.00 | 666.00 | 695.00 | 451.00 | 454.00 |
| Operating Profit | 851.00 | 690.00 | 505.00 | 431.00 | 566.00 | 408.00 | 182.00 | 172.00 |
| OPM % | 41.00 | 37.00 | 36.00 | 41.00 | 46.00 | 37.00 | 29.00 | 27.00 |
| Other Income | 158.00 | 109.00 | 70.00 | 139.00 | 49.00 | 37.00 | 21.00 | 21.00 |
| Interest | 7.00 | 9.00 | 9.00 | 9.00 | 10.00 | 17.00 | 20.00 | 18.00 |
| Depreciation | 100.00 | 78.00 | 81.00 | 64.00 | 58.00 | 62.00 | 62.00 | 61.00 |
| Profit before tax | 903.00 | 711.00 | 485.00 | 498.00 | 547.00 | 366.00 | 121.00 | 114.00 |
| Tax % | 26.00 | 29.00 | 23.00 | 23.00 | 26.00 | 26.00 | 23.00 | 32.00 |
| Net Profit | 671.00 | 506.00 | 375.00 | 386.00 | 406.00 | 271.00 | 93.00 | 77.00 |
| EPS in Rs | 11.94 | 9.05 | 6.70 | 6.76 | 462.60 | 319.77 | 110.62 | 91.97 |
| Dividend Payout % | 17.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 112.00 | 112.00 | 112.00 | 114.00 | 9.00 | 8.00 | 8.00 | 8.00 |
| Reserves | 3,072.00 | 2,361.00 | 1,821.00 | 1,628.00 | 1,347.00 | 693.00 | 413.00 | 323.00 |
| Borrowings | 50.00 | 113.00 | 173.00 | 115.00 | 35.00 | 100.00 | 159.00 | 192.00 |
| Other Liabilities | 296.00 | 249.00 | 219.00 | 136.00 | 228.00 | 232.00 | 207.00 | 194.00 |
| Total Liabilities | 3,531.00 | 2,836.00 | 2,324.00 | 1,993.00 | 1,619.00 | 1,034.00 | 787.00 | 718.00 |
| Fixed Assets | 613.00 | 624.00 | 478.00 | 449.00 | 329.00 | 361.00 | 306.00 | 316.00 |
| CWIP | 84.00 | 58.00 | 156.00 | 143.00 | 153.00 | 19.00 | 50.00 | 12.00 |
| Investments | 1,380.00 | 533.00 | 472.00 | 499.00 | 273.00 | 209.00 | 99.00 | 73.00 |
| Other Assets | 1,455.00 | 1,620.00 | 1,219.00 | 902.00 | 865.00 | 444.00 | 333.00 | 318.00 |
| Total Assets | 3,531.00 | 2,836.00 | 2,324.00 | 1,993.00 | 1,619.00 | 1,034.00 | 787.00 | 718.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 889.00 | 300.00 | 164.00 | 319.00 | 333.00 | 278.00 | 166.00 | 196.00 |
| Cash from Investing Activity | -742.00 | -250.00 | -192.00 | -378.00 | -206.00 | -196.00 | -109.00 | -121.00 |
| Cash from Financing Activity | -44.00 | -68.00 | -132.00 | 53.00 | 181.00 | -63.00 | -48.00 | -65.00 |
| Net Cash Flow | 104.00 | -18.00 | -159.00 | -6.00 | 308.00 | 18.00 | 9.00 | 9.00 |
| Free Cash Flow | 753.00 | 171.00 | 41.00 | 145.00 | 308.00 | 159.00 | 119.00 | 144.00 |
| CFO/OP % | 128.00 | 67.00 | 56.00 | 101.00 | 81.00 | 85.00 | 116.00 | 114.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 100.00 | 89.00 | 126.00 | 95.00 | 97.00 | 84.00 | 61.00 | 68.00 |
| Inventory Days | 55.00 | 167.00 | 129.00 | 139.00 | 52.00 | 29.00 | 186.00 | 123.00 |
| Days Payable | 32.00 | 54.00 | 61.00 | 77.00 | 58.00 | 50.00 | 87.00 | 72.00 |
| Cash Conversion Cycle | 122.00 | 201.00 | 194.00 | 157.00 | 91.00 | 63.00 | 160.00 | 119.00 |
| Working Capital Days | 82.00 | 128.00 | 129.00 | 114.00 | 75.00 | 27.00 | 20.00 | 22.00 |
| ROCE % | 32.00 | 31.00 | 25.00 | 28.00 | 51.00 | 55.00 | 26.00 | — |
Corporate Actions
1 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 25 Jun 2026 | 26 Jun 2026 | — | 2.00 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update2 Jul from icra
-
Rating update20 Jun 2025 from icra